Home › Funds › TANG CAPITAL MANAGEMENT LLC › IMCR
TANG CAPITAL MANAGEMENT LLC position in IMCR
IMMUNOCORE HLDGS PLC · Health Care
TANG CAPITAL MANAGEMENT LLC reported holding 2,884,149 shares of IMCR (IMMUNOCORE HLDGS PLC) in its Q3 2026 13F filing — a position valued at US$87.4M, representing 4.02% of its reported portfolio and ranking #10 among its reported holdings. TANG CAPITAL MANAGEMENT LLC has disclosed IMCR holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR
How TANG CAPITAL MANAGEMENT LLC's IMCR position evolved
TANG CAPITAL MANAGEMENT LLC first disclosed a stake in IMCR in Q3 2023 at 405,600 shares (US$21.1M). The position peaked in Q4 2025 at 2,628,538 shares, worth US$91.2M. Across 13 filings, TANG CAPITAL MANAGEMENT LLC increased the stake 8 time(s), trimmed it 0 time(s) and left it unchanged 4 time(s). The most recent filing (Q3 2026) shows 2,884,149 shares valued at US$87.4M — an increase of 234,781 shares quarter over quarter.. Notable position changes include a 173% increase in Q3 2024 (shares fell 5% over the following quarter), a 41% increase in Q4 2024 (shares were roughly flat over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 405.60K | $21.05M | New |
| Q4 2023 | 405.60K | $27.71M | Hold |
| Q1 2024 | 405.60K | $26.36M | Hold |
| Q2 2024 | 405.60K | $13.75M | Hold |
| Q3 2024 | 1.11M | $34.42M | Add |
| Q4 2024 | 1.56M | $45.89M | Add |
| Q1 2025 | 1.92M | $56.84M | Add |
| Q2 2025 | 2.11M | $66.07M | Add |
| Q3 2025 | 2.31M | $83.76M | Add |
| Q4 2025 | 2.63M | $91.24M | Add |
| Q1 2026 | 2.65M | $79.88M | Add |
| Q2 2026 | 2.65M | $84.12M | Hold |
| Q3 2026 | 2.88M | $87.36M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About IMCR and 13F data
IMCR (IMMUNOCORE HLDGS PLC) is a Health Care company. 27 other funds we track also report a position in IMCR — the largest reported positions include RTW INVESTMENTS, LP (US$147.5M), Bellevue Group AG (US$68.6M), Caligan Partners LP (US$50.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding IMCR
- RTW INVESTMENTS, LP 4.87M sh · $147.51M · Q3 2026
- Bellevue Group AG 2.26M sh · $68.59M · Q3 2026
- Caligan Partners LP 1.67M sh · $50.65M · Q3 2026
- Kynam Capital Management, LP 1.38M sh · $41.65M · Q3 2026
- BVF INC/IL 1.23M sh · $37.28M · Q3 2026
- MPM BioImpact LLC 1.20M sh · $36.45M · Q3 2026
- ARMISTICE CAPITAL, LLC 1.14M sh · $34.41M · Q3 2026
- Trails Edge Capital Partners, LP 1.06M sh · $32.21M · Q3 2026
- FARALLON CAPITAL MANAGEMENT, L.L.C. 928.00K sh · $28.11M · Q3 2026
- BRAIDWELL LP 906.12K sh · $27.45M · Q3 2026
- Vestal Point Capital, LP 850.00K sh · $25.75M · Q3 2026
- Frazier Life Sciences Management, L.P. 829.75K sh · $25.13M · Q3 2026
More on TANG CAPITAL MANAGEMENT LLC
FAQ
How long has TANG CAPITAL MANAGEMENT LLC held IMCR?
TANG CAPITAL MANAGEMENT LLC has disclosed IMCR holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is TANG CAPITAL MANAGEMENT LLC's current position in IMCR?
As of Q3 2026, TANG CAPITAL MANAGEMENT LLC holds 2.88M shares of IMCR (IMMUNOCORE HLDGS PLC), valued at $87.36M, representing 4.02% of its reported portfolio and ranking #10.
Has TANG CAPITAL MANAGEMENT LLC been buying or selling IMCR?
In the latest 13F filing (Q3 2026), TANG CAPITAL MANAGEMENT LLC increased its position in IMCR. The position peaked in Q4 2025 at 2.63M shares.
Which other funds hold IMCR?
Other major institutional holders of IMCR include RTW INVESTMENTS, LP, Bellevue Group AG, Caligan Partners LP, among 27 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.